INFI

Infinity Pharmaceuticals, Inc.
INFI

Overview Fund Activity
Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

93 hedge funds and large institutions have $38.6M invested in Infinity Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-4
Holders Change %
-4.12%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
37
Closed
15
Calls
$471K
Puts
$107K
Net Calls
+$364K
Net Calls Change
-$1.86M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$674K
2
GCP
GSA Capital Partners
United Kingdom
+$319K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$300K
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$174K
5
Morgan Stanley
Morgan Stanley
New York
+$168K

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.73M
2
Millennium Management
Millennium Management
New York
-$786K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$529K
4
CC
Callan Capital
California
-$329K
5
Marshall Wace
Marshall Wace
United Kingdom
-$323K
Name Holding Trade Value Shares
Change 		Shares
Change %
TCWM
101
Total Clarity Wealth Management
Illinois
– -$7K -3,000 Closed
EVM
102
Eaton Vance Management
Massachusetts
– -$2K -1,000 Closed
1 2 3 4
5